Dexcom CEO Terry Gregg reviews the tremendous growth the company saw in 2013 and how the company is improving the quality of life for diabetics. TheStreet's Jill Malandrino reports from the Nasdaq MarketSite in New York.
Cramer says Johnson Controls has a number of catalysts going for it starting with its forthcoming split into three companies.
The Internet is a beast. If you don't feed it, it will eat you alive, Cramer says.
Trade-Ideas LLC identified DexCom (DXCM) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate